Real-world economic impact of onabotulinumtoxinA in patients with chronic migraine. - sprookjes - yvandenbroek - TriplyDB

Real-world economic impact of onabotulinumtoxinA in patients with chronic migraine.

Real-world economic impact of onabotulinumtoxinA in patients with chronic migraine.

http://www.wikidata.org/entity/Q34806387

about

OnabotulinumtoxinA for chronic migraine: a critical appraisal.Chronic Migraine: An Update on Physiology, Imaging, and the Mechanism of Action of Two Available Pharmacologic Therapies.Real-life use of onabotulinumtoxinA for symptom relief in patients with chronic migraine: REPOSE study methodology and baseline data The use of onabotulinum toxin A (Botox(®)) in the treatment of chronic migraine at the Parma Headache Centre: a prospective observational study.Comparative effectiveness of onabotulinumtoxinA versus oral migraine prophylactic medications on headache-related resource utilization in the management of chronic migraine: Retrospective analysis of a US-based insurance claims database.OnabotulinumtoxinA in the treatment of patients with chronic migraine: clinical evidence and experience.OnabotulinumtoxinA in chronic migraine: predictors of response. A prospective multicentre descriptive study.Onabotulinum toxin A (Botox) for chronic migraine treatment: an Italian experience.

P2860

Q35822040-D439E246-0B09-43B0-958A-2C43E292DBB9 Q39026796-31B7F94D-9DD9-4852-9321-D777F8769072 Q39150092-CD4AD0E7-1638-4DDD-9126-B8D293909B13 Q39860994-EFB732DA-3DDC-409A-8297-A7B1A9C182C9 Q40183047-027FACE0-0308-4C3D-8351-C0A053FC8EA0 Q47105597-A5BA8709-5217-4801-A3BC-EA64CF941168 Q47420416-8C2ECE6A-69E8-4EE4-A0E3-AC556150B23C Q48037570-A134D8F9-E7DA-4E1A-8EB6-9AAF359A38DA

P2860

Real-world economic impact of onabotulinumtoxinA in patients with chronic migraine.

http://www.wikidata.org/entity/Q34806387

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Real-world economic impact of onabotulinumtoxinA in patients with chronic migraine.

@ast

Real-world economic impact of onabotulinumtoxinA in patients with chronic migraine.

@en

Real-world economic impact of onabotulinumtoxinA in patients with chronic migraine.

@nl

type

label

Real-world economic impact of onabotulinumtoxinA in patients with chronic migraine.

@ast

Real-world economic impact of onabotulinumtoxinA in patients with chronic migraine.

@en

Real-world economic impact of onabotulinumtoxinA in patients with chronic migraine.

@nl

prefLabel

Real-world economic impact of onabotulinumtoxinA in patients with chronic migraine.

@ast

Real-world economic impact of onabotulinumtoxinA in patients with chronic migraine.

@en

Real-world economic impact of onabotulinumtoxinA in patients with chronic migraine.

@nl

P1433

Q34806387-E8866868-EA59-40C4-9446-B38F84CD9D9C

P1476

Q34806387-8C6837FA-11BC-43F2-8E56-565884B14488

P2093

Q34806387-4AE01D4A-F290-4351-818A-6BCB0173DE86

Q34806387-5DF136BE-A126-4B76-A7A7-CB975742F058

Q34806387-6C4BCE98-E4A2-4F6B-940E-FBA53948EF8C

Q34806387-AD195A13-290E-41F7-926E-E049195FCFC0

P2860

Q34806387-0C1BB250-D037-4004-9360-6E5CCE70AFFD

Q34806387-47053B1A-6CB2-4184-B6D0-872F7312CD67

Q34806387-600BD021-0325-4660-BBEB-4F8B1ACCE877

Q34806387-6834534F-8DAC-43EB-972C-44C5728583A1

Q34806387-92DF08B5-2EBC-40A4-91EA-804076DB8628

Q34806387-A154FB71-7CD8-44DC-97D0-E973B204A116

Q34806387-ADE9355A-9B75-4C25-A07F-D1C88DD105D9

Q34806387-BA22CC56-0C81-475D-9042-18710B4207B4

Q34806387-C02C84A8-C209-4F90-8017-9AA402A497CC

Q34806387-C526EBA7-A5DB-47EE-88D3-EDA720D826C0

P304

Q34806387-0A1104EF-556E-474E-8B73-3BECC0C7C30F

P31

Q34806387-63A2D65B-E519-4B06-85B2-5A0E48D315DF

P356

Q34806387-F2370A1C-1A36-44CC-B21F-E7F192F19175

P433

Q34806387-ECC45781-C005-4C5E-BCBF-3009B140C6DE

P478

Q34806387-3605D530-2089-46AE-A836-DBB2D36DBCC2

P50

Q34806387-350D6C19-A80B-4E34-8ECF-E3FA14080684

P577

Q34806387-7D3D0690-C9E6-43A5-BA9A-EC3D50BFF18D

P5875

Q34806387-17284BC7-AA21-4BD4-ACE5-D4B652EDB7EE

P698

Q34806387-9D375B0E-6F4E-4640-B1B6-0A9BFAB10957

P921

Q34806387-75D16FF4-C6EF-44A0-8CF1-46C6DF2E0EDF

P932

Q34806387-511445AE-1547-4800-B96D-79542EFB8283

P356

P1433

P1476

Real-world economic impact of onabotulinumtoxinA in patients with chronic migraine.

@en

P2093

Diane Andress-Rothrock

http://www.w3.org/2001/XMLSchema#string

John F Rothrock

http://www.w3.org/2001/XMLSchema#string

Lisa M Bloudek

http://www.w3.org/2001/XMLSchema#string

Sepideh F Varon

http://www.w3.org/2001/XMLSchema#string

P2860

Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability.

OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.

Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS).

Rescue therapy for acute migraine, part 1: triptans, dihydroergotamine, and magnesium.

The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 Medication-overuse headache.

Global prevalence of chronic migraine: a systematic review.

Method of injection of onabotulinumtoxinA for chronic migraine: a safe, well-tolerated, and effective treatment paradigm based on the PREEMPT clinical program.

Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers.

Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study.

Employment and work impact of chronic migraine and episodic migraine.

P304

1565-1573

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/HEAD.12456

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P50

Timothy T Houle

P577

2014-10-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266683311

http://www.w3.org/2001/XMLSchema#string

P698

25298117

http://www.w3.org/2001/XMLSchema#string

P921

migraine disorder

P932

4282490

http://www.w3.org/2001/XMLSchema#string